Literature DB >> 20107825

Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity.

Johann Steiner1, Roland Jacobs, Benjamin Panteli, Mareike Brauner, Kolja Schiltz, Sabine Bahn, Marlis Herberth, Sabine Westphal, Tomasz Gos, Martin Walter, Hans-Gert Bernstein, Aye Mu Myint, Bernhard Bogerts.   

Abstract

Previous studies of lymphocyte distribution in schizophrenia have yielded inconsistent results, as summarized in the present study. Based on our own original data, potential confounds that might explain these variations are analyzed and discussed. Blood samples from 26 patients with acute paranoid schizophrenia were investigated in comparison with 32 matched healthy controls by flow cytometry (CD3, CD4, CD8, CD19, and CD56 phenotyping). A subgroup of drug-free patients was followed up after 6 weeks of treatment. Cotinine levels and the free cortisol index (FCI) were provided in order to control for medication, smoking, and stress. Cotinine levels correlated with natural killer (NK) cell counts (CD3⁻/CD56(+): r = -0.383, P = 0.003) while the FCI was related to B cell numbers (CD19(+): r = 0.390, P = 0.003). Considering these covariates, a lower level of T helper cells (P = 0.010), a reduced CD4/CD8 ratio (P = 0.029), and elevated B cells (P = 0.008) were found during acute psychosis. After 6 weeks of medication, an inverse pattern was observed in initially drug-free patients: total T cell (P = 0.005), T helper (P = 0.003), and T suppressor/cytotoxic cells (P = 0.005) increased, while B cell counts declined (P = 0.049). In conclusion, acute paranoid schizophrenia may be accompanied by a reduced T cell defense and a shift towards B cell immunity, which normalizes in response to treatment. In addition to disease stage or subtype and medication, cigarette smoking and stress are important co-factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107825     DOI: 10.1007/s00406-010-0098-x

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  55 in total

1.  Decreased T cellular immune response in schizophrenic patients.

Authors:  Michael Riedel; Ilja Spellmann; Markus J Schwarz; Martin Strassnig; Christopher Sikorski; Hans-Jürgen Möller; Norbert Müller
Journal:  J Psychiatr Res       Date:  2006-01-24       Impact factor: 4.791

2.  Antibodies against cerebral M1 cholinergic muscarinic receptor from schizophrenic patients: molecular interaction.

Authors:  Tania Borda; Ricardo Perez Rivera; Lilian Joensen; Ricardo M Gomez; Leonor Sterin-Borda
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

Review 3.  Cytomegalovirus and schizophrenia.

Authors:  E Fuller Torrey; Markus F Leweke; Markus J Schwarz; Norbert Mueller; Silke Bachmann; Johannes Schroeder; Faith Dickerson; Robert H Yolken
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Habituation of cortisol responses to repeated psychosocial stress-further characterization and impact of genetic factors.

Authors:  Stefan Wüst; Ilona S Federenko; Elisabeth F C van Rossum; Jan W Koper; Dirk H Hellhammer
Journal:  Psychoneuroendocrinology       Date:  2005-02       Impact factor: 4.905

5.  Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.

Authors:  Stéphane Potvin; Emmanuel Stip; Amir A Sepehry; Alain Gendron; Ramatoulaye Bah; Edouard Kouassi
Journal:  Biol Psychiatry       Date:  2007-11-19       Impact factor: 13.382

6.  [Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication].

Authors:  Seda Celik Baskak; Hüseyin Ozsan; Bora Baskak; Halise Devrimci Ozgüven; Gülay Kinikli
Journal:  Turk Psikiyatri Derg       Date:  2008

7.  Immunological dysfunction in schizophrenia: a systematic approach.

Authors:  M Rothermundt; V Arolt; C Weitzsch; D Eckhoff; H Kirchner
Journal:  Neuropsychobiology       Date:  1998       Impact factor: 2.328

Review 8.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

9.  Chronic self-administration of nicotine in rats impairs T cell responsiveness.

Authors:  Roma Kalra; Shashi P Singh; Dean Kracko; Shannon G Matta; Burt M Sharp; Mohan L Sopori
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

10.  Changes of immunological functions after acute exacerbation in schizophrenia.

Authors:  T Sasaki; S Nanko; R Fukuda; T Kawate; H Kunugi; H Kazamatsuri
Journal:  Biol Psychiatry       Date:  1994-02-01       Impact factor: 13.382

View more
  26 in total

Review 1.  Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Authors:  Jianchun Xiao; Emese Prandovszky; Geetha Kannan; Mikhail V Pletnikov; Faith Dickerson; Emily G Severance; Robert H Yolken
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

Review 2.  Psychosis: an autoimmune disease?

Authors:  Adam A J Al-Diwani; Thomas A Pollak; Sarosh R Irani; Belinda R Lennox
Journal:  Immunology       Date:  2017-08-03       Impact factor: 7.397

Review 3.  Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: current knowledge and clinical implications.

Authors:  Johann Steiner; Kolja Schiltz; Hans-Gert Bernstein; Bernhard Bogerts
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

4.  Abnormal levels of vascular endothelial biomarkers in schizophrenia.

Authors:  Tanya T Nguyen; Sheena I Dev; Guanqing Chen; Sharon C Liou; Averria Sirkin Martin; Michael R Irwin; Judith E Carroll; Xin Tu; Dilip V Jeste; Lisa T Eyler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-09-23       Impact factor: 5.270

Review 5.  Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications.

Authors:  Monojit Debnath; Michael Berk
Journal:  Schizophr Bull       Date:  2014-04-07       Impact factor: 9.306

6.  A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis?

Authors:  Elfi Vergaelen; Carmen Schiweck; Kristof Van Steeland; Jacqueline Counotte; Wim Veling; Ann Swillen; Hemmo Drexhage; Stephan Claes
Journal:  Brain Behav Immun       Date:  2018-03-19       Impact factor: 7.217

Review 7.  Psychiatric disorders in toxoplasma seropositive patients--the CD8 connection.

Authors:  Rajarshi Bhadra; Dustin A Cobb; Louis M Weiss; Imtiaz A Khan
Journal:  Schizophr Bull       Date:  2013-02-20       Impact factor: 9.306

8.  Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Bintou Gassama; Dale Sebastian; Peter Buckley; Andrew Mellor
Journal:  Biol Psychiatry       Date:  2012-10-11       Impact factor: 13.382

9.  Biomarkers, population-based studies and a proof of principle investigation in pharmacotherapy.

Authors:  P Falkai; H-J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-10       Impact factor: 5.270

10.  Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia.

Authors:  Jonathan L Hess; Daniel S Tylee; Rahul Barve; Simone de Jong; Roel A Ophoff; Nishantha Kumarasinghe; Paul Tooney; Ulrich Schall; Erin Gardiner; Natalie Jane Beveridge; Rodney J Scott; Surangi Yasawardene; Antionette Perera; Jayan Mendis; Vaughan Carr; Brian Kelly; Murray Cairns; Ming T Tsuang; Stephen J Glatt
Journal:  Schizophr Res       Date:  2016-07-20       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.